EP08.02-140. MET Biomarker-based Preliminary Efficacy Analysis in SAVANNAH: savolitinib+osimertinib in EGFRm NSCLC Post-Osimertinib
Back to course
Pdf Summary
Asset Subtitle
Myung-Ju Ahn
Meta Tag
Speaker Myung-Ju Ahn
Topic Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
Keywords
study
efficacy
safety
savolitinib
osimertinib
non-small cell lung cancer
resistance
MET-related resistance
combination treatment
MET overexpression
Powered By